Recent Projects
AlcheraBio continues to be involved in the development of some leading-edge animal health products and technologies. The majority of AlcheraBio’s current and recent projects and clients are proprietary, so we can’t comment on them publicly. We are currently conducting several GCP and postmarketing studies. In July 2006, a publication in Veterinary Therapeutics Vol. 7 No. 2, entitled Clinical Effectiveness and Safety of a New NSAID, Firocoxib: A 1,000-Dog Study, reported on a 2005 postmarketing study of an approved canine product for treating osteoarthritis-associated pain and inflammation. Katherine Moldave was a co-author. A second publication related to that particular study is pending.